Nacl + Glucose Viaflo Baxter (Sodium Chloride, Glucose Monohydrate)

Nacl + Glucose Viaflo Baxter is used in clinical situations that require rapid fluid and electrolyte restoration.

• Fluid replacement: Restores intravascular volume in dehydration, blood loss, or peri‑operative settings.
• Electrolyte replenishment: Provides sodium and chloride to correct electrolyte deficits.
• Hypoglycemia: Supplies glucose to raise blood sugar in acute low‑glucose episodes.

• The injection delivers sodium chloride, which expands extracellular fluid and restores osmotic balance, while glucose monohydrate supplies an immediate source of carbohydrate for cellular metabolism. Together they increase plasma osmolality, promote water movement into the vascular compartment, and support energy production, thereby correcting hypovolemia and hypoglycemia.

Adverse reactions may occur with any intravenous solution.

Common Side Effects

• Phlebitis or infusion site pain: irritation of the vein during administration.
• Mild hypernatremia: transient rise in serum sodium.
• Transient hyperglycemia: temporary increase in blood glucose levels.
• Fluid overload: signs of edema or pulmonary congestion in susceptible patients.
• Electrolyte imbalance: minor shifts in potassium or chloride.

Serious or Rare Side Effects

• Severe hypernatremia: neurological symptoms such as confusion or seizures.
• Anaphylactic reaction: rare but possible hypersensitivity to formulation components.
• Cardiac arrhythmia: precipitated by rapid electrolyte changes.
• Infection at infusion site: bacterial contamination leading to local or systemic infection.
• Metabolic acidosis: unlikely but reported with large volumes.

Careful assessment and monitoring are essential when using this intravenous solution.

• Assess electrolyte status: verify serum sodium and glucose before infusion.
• Monitor fluid balance: track input/output and signs of overload.
• Adjust for renal impairment: reduce volume in patients with reduced clearance.
• Use compatible IV sets: avoid mixing with incompatible drugs.
• Observe for allergic reactions: discontinue if hypersensitivity occurs.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Certain concomitant therapies can modify the safety or efficacy of the solution.

Major Interactions (Avoid)

• Hypertonic saline infusions: may cause excessive sodium load.
• High‑dose glucose infusions: increase risk of severe hyperglycemia.
• Loop diuretics: can exacerbate electrolyte shifts when combined with large volumes.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: may potentiate hypotensive effects.
• NSAIDs: can affect renal handling of sodium and fluid.
• Insulin therapy: requires close glucose monitoring to avoid hypoglycemia after glucose infusion.